IPOPLUS

₹767.5

▼ -2.15 -0.28%

18 Jun 2026

NSE Listed · Pharmaceuticals

Anthem Biosciences Ltd. (ANTHEM)

Volume: 31,151Avg Vol 1W: 2,05,571Avg Vol 1M: 2,28,64452W Range:₹579.15₹873.5
NSE BSE
₹767.5▼ 0.28%
Key Ratios
Updated just now
Market Cap₹44,414 Cr
Current Price₹767.5
Previous Close₹769.65
High / Low (52w)₹873.5 / ₹579.15
Volume31,151
Avg Vol (1W)2,05,571
Avg Vol (1M)2,28,644
Stock P/E—
Book Value₹54.17
Dividend Yield0.25%
ROE19.45%
ROA17.26%
Revenue (TTM)—
Revenue Growth29.96%
Profit Margin27.86%
Total Debt₹47 Cr
Shares Outstanding56 Cr
Face Value₹2
EPS (TTM)₹3.38
P/B14.48
Debt / Equity0.02
50 DMA₹774.62
200 DMA₹703.76
Day change-0.28%
Price Chart
₹767.5▲ 3.28% · 1Y
₹820₹5892.1Cr
2025-10-21
2026-06-16

20-day avg volume: 2.4L shares

Pros
  • Healthy return on equity of 19.4%.
  • Company is almost debt-free.
  • Revenue grew 30% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024
Revenue₹611 Cr₹423 Cr₹550 Cr₹540 Cr₹483 Cr₹498 Cr₹525 Cr₹339 Cr
EBITDA₹279 Cr₹156 Cr₹233 Cr₹188 Cr₹179 Cr₹164 Cr₹203 Cr₹122 Cr
Net Profit₹190 Cr₹93 Cr₹173 Cr₹136 Cr₹83 Cr₹124 Cr₹162 Cr₹82 Cr
EPS3.341.643.092.421.472.212.841.47
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹1,930 Cr₹1,483 Cr₹1,134 Cr₹1,280 Cr₹1,140 Cr₹653 Cr
EBITDA₹667 Cr₹487 Cr₹442 Cr₹556 Cr₹383 Cr₹141 Cr
Net Profit₹451 Cr₹367 Cr₹385 Cr₹406 Cr₹271 Cr₹93 Cr
EPS8.046.486.75467.53323.41108
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹2,808 Cr₹2,398 Cr₹2,014 Cr₹1,619 Cr₹1,034 Cr₹787 Cr
Total Liabilities₹398 Cr₹473 Cr₹274 Cr₹264 Cr₹332 Cr₹365 Cr
Equity₹2,410 Cr₹1,925 Cr₹1,741 Cr₹1,355 Cr₹701 Cr₹422 Cr
Total Debt₹47 Cr₹112 Cr₹96 Cr₹6 Cr₹20 Cr₹95 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹577 Cr₹260 Cr₹421 Cr₹456 Cr₹348 Cr₹211 Cr
Investing₹-152 Cr₹-221 Cr₹-376 Cr₹-205 Cr₹-196 Cr₹-109 Cr
Financing₹-134 Cr₹-77 Cr₹64 Cr₹181 Cr₹-63 Cr₹-48 Cr
Free Cash Flow₹577 Cr₹260 Cr₹421 Cr₹456 Cr₹348 Cr₹211 Cr
Shareholding
Promoter 74.68% Institutions 12.83% Public 12.5%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search